a From the Department of Laboratory Medicine (LABMED), Division of Clinical Microbiology , Karolinska University Hospital , Stockholm , Sweden.
b Department of Medical Biochemistry and Microbiology , Uppsala University , Uppsala , Sweden.
Infect Dis (Lond). 2016;48(1):18-25. doi: 10.3109/23744235.2015.1062536. Epub 2015 Jul 1.
Bacteria producing extended-spectrum β-lactamases (ESBLs) constitute a globally increasing problem that contributes to treatment complications and elevated death rates. The extremely successful dissemination by ESBL-producing Enterobacteriaceae during the latest decades is a result of the combination of mobilization, evolution and horizontal spread of β-lactamase genes on plasmids. In parallel, spread of these plasmids to particularly well-adapted bacterial clones (outbreak clones) has expanded. In this review we describe ESBL-producing bacteria and the genetic mechanisms for dissemination of ESBL resistance. We describe available methodology for studying plasmids and the importance of including plasmids in epidemiological typing as natural parts of the organisms. Plasmids play a fundamental role in how resistance arises and disseminates.
产超广谱β-内酰胺酶(ESBL)的细菌是一个全球性日益严重的问题,导致治疗并发症和死亡率升高。在最近几十年,产 ESBL 的肠杆菌科细菌的成功传播是由于β-内酰胺酶基因在质粒上的移动、进化和水平传播的结合。与此同时,这些质粒传播到特别适应的细菌克隆(暴发克隆)的情况也有所扩大。在这篇综述中,我们描述了产 ESBL 的细菌和传播 ESBL 耐药性的遗传机制。我们描述了用于研究质粒的现有方法,以及将质粒纳入流行病学分型作为生物体自然部分的重要性。质粒在耐药性的产生和传播中起着至关重要的作用。